Kaposi's sarcoma (KS)-associated herpesvirus (KSHV), or human herpesvirus 8 (HHV-8), was originally isolated from a KS lesion. KS is a vascular tumor of the skin that is the leading neoplasm of AIDS patients. It is now clear that KSHV is consistently found in all forms of KS (classical, endemic, post transplant, and AIDS-related), resulting in the widely held view that KSHV is the etiologic agent of KS. Infected cells in KS lesions include endothelial cells, spindle cells and immune infiltrating cells. KSHV infection of human endothelial cells causes long-term proliferation and survival of these cells. Inflammatory cytokines and innate immune responses are critical components of KS lesions facilitating paracrine-mediated promotion of angiogenesis and lytic versus latency states in infected cells. The mechanism by which KSHV activates inflammatory and innate immune responses is unknown. Recent discoveries from our laboratory have revealed that innate responses are triggered by envelope glycoproteins during, or in concert with, virus entry. The goal of this project is to define the initial interactions between KSHV envelope proteins and endothelial cell molecules and to characterize the immediate and long-term consequences of these interactions. The central hypothesis of this project is that interactions between KSHV envelope proteins with the microvascular endothelium trigger signal transduction pathways that lead to activation of innate and inflammatory immune responses characterized by substantial reprogramming of cellular transcription. Preliminary data show that purified KSHV K8. 1 glycoprotein activates a key mediator of interferon induction and induces an antiviral state in cells. This finding lends fundamental support to the overall hypothesis. To characterize alterations in cellular gene expression as a consequence of KSHV:cell interactions, transcriptional profiling and direct assessment of induced key innate immune activators will be measured. Other experiments are designed to elucidate the cellular machinery involved in transmission of extracellular-derived signals by KSHV envelope proteins. The final objective of this project is to identify the initiating mechanism of the iinnate activation responses. The relative contribution of known KSHV cell binding partners, heparan sulfate proteoglycans and alpha3beta1 integrins will be evaluated. In addition, we will directly test the hypothesis that KSHV is subject to innate sensing by Toll-like receptors, ancient defense molecules that transmit activation responses. Successful completion of these research goals will yield new insights into KSHV pathogenesis/tumorigenesis as well as have implications for future vaccine design.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA022443-26
Application #
6753101
Study Section
Special Emphasis Panel (ZCA1-GRB-I (J1))
Project Start
2003-05-29
Project End
2008-04-30
Budget Start
Budget End
2004-04-30
Support Year
26
Fiscal Year
2003
Total Cost
$162,025
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Chiu, Ya-Fang; Sugden, Bill (2018) Plasmid Partitioning by Human Tumor Viruses. J Virol 92:
Shin, Myeong-Kyun; Payne, Susan N; Bilger, Andrea et al. (2018) Activating Mutations in Pik3caContribute to Anal Carcinogenesis in the Presence or Absence of HPV-16 Oncogenes. Clin Cancer Res :
Hoebe, Eveline; Wille, Coral; Hagemeier, Stacy et al. (2018) Epstein-Barr Virus Gene BARF1 Expression is Regulated by the Epithelial Differentiation Factor ?Np63? in Undifferentiated Nasopharyngeal Carcinoma. Cancers (Basel) 10:
Nyman, Patrick E; Buehler, Darya; Lambert, Paul F (2018) Loss of Function of Canonical Notch Signaling Drives Head and Neck Carcinogenesis. Clin Cancer Res 24:6308-6318
Weng, Chao; Lee, Denis; Gelbmann, Christopher B et al. (2018) Human Cytomegalovirus Productively Replicates In Vitro in Undifferentiated Oral Epithelial Cells. J Virol 92:
Bristol, Jillian A; Djavadian, Reza; Albright, Emily R et al. (2018) A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection. PLoS Pathog 14:e1007179
Romero-Masters, James C; Ohashi, Makoto; Djavadian, Reza et al. (2018) An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. PLoS Pathog 14:e1007221
UmaƱa, Angie C; Iwahori, Satoko; Kalejta, Robert F (2018) Direct Substrate Identification with an Analog Sensitive (AS) Viral Cyclin-Dependent Kinase (v-Cdk). ACS Chem Biol 13:189-199
Meyers, Jordan M; Grace, Miranda; Uberoi, Aayushi et al. (2018) Inhibition of TGF-? and NOTCH Signaling by Cutaneous Papillomaviruses. Front Microbiol 9:389
Uberoi, Aayushi; Yoshida, Satoshi; Lambert, Paul F (2018) Development of an in vivo infection model to study Mouse papillomavirus-1 (MmuPV1). J Virol Methods 253:11-17

Showing the most recent 10 out of 434 publications